Please select the option that best describes you:
What are your top takeaways in Melanoma from ASCO 2022?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
Answer from: Medical Oncologist at Academic Institution
1. Melanoma oral abstract session #3: Abstract 9502 Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512)Desmoplastic melanoma is a rare subtype of melanoma that frequently occurs in the head/neck area and is very difficult to completely resect due to its invasivene...
Sign in or Register to read more